Brief: NeuroVive enters research agreements in NASH and hepatocellular carcinoma

Abliva AB

22/02/2017 09:30

Feb 22 (Reuters) - NeuroVive Pharmaceutical Ab  NVP.ST : 
    * Says appoints recognized scientific advisors and enters 
research agreements in NASH and hepatocellular carcinoma 
 
Source text for Eikon:  ID:nWkr1bMq7g  
Further company coverage:  NVP.ST  
 
 ((Olof.Swahnberg@thomsonreuters.com;))